Steve Schonfeld’s Benitec Biopharma BNTC Stock Holding History

Steve Schonfeld’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.15M	Buy	235,357 +82,178	+54%	+$975K	0.01%	841
2026 Q1	$1.63M	Sell	153,179 -109,026	-42%	-$1.26M	0.01%	902
2025 Q4	$3.53M	Buy	262,205 +1,786	+0.7%	+$24.7K	0.02%	673
2025 Q3	$3.65M	Buy	260,419 +2	+0%	+$26	0.02%	737
2025 Q2	$3.05M	Sell	260,417 -1,347	-0.5%	-$18.8K	0.02%	776
2025 Q1	$3.41M	Buy	261,764 +1,347	+0.5%	+$16.3K	0.02%	678
2024 Q4	$3.29M	Sell	260,417 -12,400	-5%	-$134K	0.02%	637
2024 Q3	$2.51M	Buy	272,817 +12,400	+5%	+$111K	0.02%	790
2024 Q2	$1.82M	Buy	+260,417	New	+$1.92M	0.01%	945

Other funds holding BNTC

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Steve Schonfeld's BNTC Position: Q2 2026 in Review

Steve Schonfeld increased its Benitec Biopharma (BNTC) stake by 54% in Q2 2026, buying an estimated $975K and bringing the position to 235,357 shares worth $3.15M. The position accounts for 0.01% of the portfolio, ranked #841.

Steve Schonfeld first reported a position in BNTC in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.65M in Q3 2025. 86 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

Steve Schonfeld held 235,357 shares of Benitec Biopharma worth $3.15M as of Q2 2026.
Steve Schonfeld bought 82,178 Benitec Biopharma shares in Q2 2026, an estimated $975K.
Benitec Biopharma made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #841 holding.
Steve Schonfeld first reported a position in Benitec Biopharma in Q2 2024 and has held it in 9 quarters since.
Steve Schonfeld's Benitec Biopharma position peaked at $3.65M in Q3 2025.
86 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.